Search Results for 'Cirrhosis-Weeks'

Cirrhosis-Weeks published presentations and documents on DocSlides.

Hepatitis C Imtiaz Alam, M.D.
Hepatitis C Imtiaz Alam, M.D.
by olivia-moreira
Medical Director, Austin Hepatitis Center. 1. Hep...
MM: HCV and Cirrhosis Patient Case
MM: HCV and Cirrhosis Patient Case
by devin732
Chris Kolkman. PrimaryOne. Health. Meet MM. Patie...
Liver Cirrhosis GNT block
Liver Cirrhosis GNT block
by elise
Dec 2019. Liver cirrhosis. Objectives: . Define Ci...
Management of Cirrhosis for the Primary Care Provider
Management of Cirrhosis for the Primary Care Provider
by norah
Nicholas Lim, MD. Associate Professor of Medicine....
Management of cirrhosis Dr
Management of cirrhosis Dr
by eliza
Nowlan Selvapatt. Consultant Hepatologist. Imperia...
LIVER CIRRHOSIS –  AYURVEDIC
LIVER CIRRHOSIS – AYURVEDIC
by paisley
TREATMENT . Dr. . Vikram. . Chauhan. is One of ...
HBV related cirrhosis Geoff Dusheiko
HBV related cirrhosis Geoff Dusheiko
by maxasp
Kings College Hospital London UK. . 20–50%. . ...
 Decompensated cirrhosis Clinical Practice Guidelines
Decompensated cirrhosis Clinical Practice Guidelines
by kittie-lecroy
About these slides. These slides give a comprehen...
Cirrhosis and complications
Cirrhosis and complications
by conchita-marotz
Best of ILC 2018. About these slides. These slide...
Liver Cirrhosis
Liver Cirrhosis
by giovanna-bartolotta
KNH 411. Morgan . Deihs. Lydia Dysart. Objectives...
LIVER CIRRHOSIS –
LIVER CIRRHOSIS –
by danika-pritchard
AYURVEDIC . TREATMENT . Dr. . Vikram. . Chauhan....
Cirrhosis of the Liver
Cirrhosis of the Liver
by phoebe-click
Kelsey Conrad. Annelise. . Chmelik. September 24...
WEEKS ENDING LOG 2014-2015
WEEKS ENDING LOG 2014-2015
by giovanna-bartolotta
Weeks Weeks Ending Ending Saturday Saturday Weeks...
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
by hezekiah
FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...
HCV 2016  Alex Rodgers Hepatologist
HCV 2016 Alex Rodgers Hepatologist
by radions
. FMC. Disclosures. nil. Learning objectives/. t. ...
C-SWIFT Study: elbasvir/grazoprevir + SOF
C-SWIFT Study: elbasvir/grazoprevir + SOF
by myesha-ticknor
in genotypes 1 or 3, with or without cirrhosis. &...
C-SWIFT Study: elbasvir/grazoprevir + SOF
C-SWIFT Study: elbasvir/grazoprevir + SOF
by pamella-moone
in genotypes 1 or 3, with or without cirrhosis. &...
Ledipasvir-Sofosbuvir + RBV in Decompensated Cirrhosis or Post-Liver Transplantation
Ledipasvir-Sofosbuvir + RBV in Decompensated Cirrhosis or Post-Liver Transplantation
by ahmir653
SOLAR-2. Source: . Manns. M, et al. Lancet Infect...
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
by ahmir
ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...
Chronic hepatitis C: guidelines for screening and
Chronic hepatitis C: guidelines for screening and
by aaron
treatment. Lisa M. Glass, MD. Clinical Lecturer. ...
www.hcvadvocate.org BLOG:  hcvadvocate.blogspot.com
www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com
by luanne-stotts
. HCV Training Workshop. Version 19.0. HCSP/HCV ...
C-WORTHY/B
C-WORTHY/B
by stefany-barnette
Randomisation*. Open-label. >. 18 years. HCV ...
Cholestasis and Cirrhosis
Cholestasis and Cirrhosis
by jasiah993
Khairat. . Battah,. . MD. Lecturer/. . consulta...
NOTES: Rates for  15 –
NOTES: Rates for 15 –
by abigail
24 . for most years are unreliable due to small si...
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
by della
Kristen M. Marks, MD. Assistant Professor. Weill C...
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
by badra
Duke University School of Medicine. Durham, North ...
Insight into the  history
Insight into the history
by elizabeth
of hepatitis C virus (HCV. ) infection; . a cohort...
Translational Liver Consortia:
Translational Liver Consortia:
by susan2
TLC and THCCC. Hashem B. El-Serag, MD, MPH. Chair ...
Liver issues for the  Rhuematologist
Liver issues for the Rhuematologist
by cappi
David Wong, MD. University of Toronto. www.toronto...
PRIMARY BILIARY CIRRHOSIS
PRIMARY BILIARY CIRRHOSIS
by faith
PRESENTED BY : . Hawa-A-Elbarghthi. Marwa-A- . Elf...
effusions
effusions
by trinity
leural occur in 5% to 10% of patients with cirrhos...
FROM CIRRHOSIS TO PARAPARESIS
FROM CIRRHOSIS TO PARAPARESIS
by morton
211 Corresponding author: PORTAbbreviationsCRP ...
archiv euromedica  31303130  29ol 2830  num
archiv euromedica 31303130 29ol 2830 num
by wilson
| archiv euromedica  ol...
PTS phase 2a - LIVER Annette
PTS phase 2a - LIVER Annette
by BlueEyedBeauty
chanzu. and Shreya agrawal. The peer teaching soc...
COMPLICATIONS OF LIVER CIRRHOSIS
COMPLICATIONS OF LIVER CIRRHOSIS
by elyana
DR. SANJANA BHAGWAT. MODERATOR : DR. SHIMPA SHARMA...
Ascites and  Hepatocellular carcinoma
Ascites and Hepatocellular carcinoma
by jocelyn
Curtis Barry, MD. UMASS ECHO. April 21, 2017. Asci...
Perazzo H et al
Perazzo H et al
by kylie
2017 16 2 269-278the DC the underlying cause was d...
HEPATOBILIARY AND PANCREATIC DISORDERS
HEPATOBILIARY AND PANCREATIC DISORDERS
by enjoinsamsung
Dr. NADIA HAMEED. Bilirubin . Jundice. (Icterus)....
Hepatocellular Carcinoma in the Absence of Cirrhosis
Hepatocellular Carcinoma in the Absence of Cirrhosis
by pinperc
Richa Shukla. Faculty mentor: Dr. Sahil Mittal. Fe...